In conclusion, the third-generation cephalosporins are reported herein as GSK3β covalent inhibitors, offering insight into the mechanism behind their benefits in cancer and Alzheimer's disease. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.